Press release
Investigation announced for Long-Term Investors in shares of Longeveron Inc. (NASDAQ: LGVN)
An investigation on behalf of current long term investors in Longeveron Inc. (NASDAQ: LGVN) shares.
Investors who are current long term investors in Longeveron Inc. (NASDAQ: LGVN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LGVN stocks follows a lawsuit filed against Longeveron Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: LGVN stocks, concerns whether certain Longeveron directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of Florida the plaintiff alleges on behalf of investors of Longeveron Inc. (NASDAQ: LGVN) who purchased or otherwise acquired Longeveron Inc. (NASDAQ: LGVN) Class A common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's IPO and/or who purchased Longeveron Inc. (NASDAQ: LGVN) securities between February 12, 2021 and August 12, 2021, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose between February 12, 2021 and August 12, 2021 that Lomecel-B was not as effective in treating aging frailty as Defendants had led investors to believe, that accordingly, Lomecel-B's clinical and commercial prospects with respect to aging frailty were overstated, and that as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.
Those who purchased shares of Longeveron Inc. (NASDAQ: LGVN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Longeveron Inc. (NASDAQ: LGVN) here
News-ID: 2488970 • Views: …
More Releases from Shareholders Foundation
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
More Releases for Longeveron
Hypoplastic Left Heart Syndrome Market Outlook 2032 - Clinical Trials, Market Si …
DelveInsight forecasts that the HLHS market will continue to evolve, supported by increasing awareness, early detection, and collaborative research in pediatric cardiology. As new therapies move through the pipeline and healthcare systems adopt personalized approaches, HLHS care is poised for meaningful advancements through 2034.
DelveInsight's recent report, "Hypoplastic Left Heart Syndrome (HLHS) - Market Insight, Epidemiology, and Market Forecast - 2032," delivers an in-depth overview of the HLHS landscape across key…
Alzheimer's Disease Drug Development Pipeline: 2025-A Surge in Innovation as 110 …
DelveInsight unveils its latest report, highlighting the evolving landscape of the Alzheimer's disease pipeline, with over 110 pharma and biotech companies like BioVie, Novo Nordisk, Alector, Longeveron, Cognition Therapeutics, TrueBinding, VT BIO, Luye Pharma Group, Lexeo Therapeutics, Merck Sharp & Dohme LLC, and Regeneration Biomedical, advancing novel Alzheimer's disease drugs set to reshape the Alzheimer's disease market.
The fight against Alzheimer's disease is gaining momentum. In its newly released "Alzheimer's disease…
Metabolic Syndrome Market to Exhibit Rapid Growth Rate During the Forecast Perio …
DelveInsight's "Metabolic Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Metabolic Syndrome, historical and forecasted epidemiology as well as the Metabolic Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Metabolic Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Metabolic Syndrome Market Forecast
https://www.delveinsight.com/sample-request/metabolic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Metabolic Syndrome Market to Exhibit Rapid Growth Rate During the Forecast Perio …
DelveInsight's "Metabolic Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Metabolic Syndrome, historical and forecasted epidemiology as well as the Metabolic Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Metabolic Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Metabolic Syndrome Market Forecast
https://www.delveinsight.com/sample-request/metabolic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Deadline on Nov. 12th coming up in Lawsuit for Investors in Longeveron Inc. (NAS …
A deadline is coming up on November 12, 2021 in the lawsuit filed for certain investors of Longeveron Inc. (NASDAQ: LGVN) over alleged securities laws violations by Longeveron Inc.
Investors who purchased shares of Longeveron Inc. (NASDAQ: LGVN) have certain options and there are strict and short deadlines running. Deadline: November 12, 2021. NASDAQ: LGVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Lawsuit filed for Investors in shares of Longeveron Inc. (NASDAQ: LGVN)
An investor, who purchased shares of Longeveron Inc. (NASDAQ: LGVN), filed a lawsuit over alleged Securities Laws violations by Longeveron Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Longeveron Inc. (NASDAQ: LGVN) have certain options and for certain investors are short and strict deadlines running. Deadline: November 12, 2021. NASDAQ: LGVN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
